TD Waterhouse Canada’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.65M Buy
74,856
+3,399
+5% +$146K 0.01% 475
2026
Q1
$2.61M Buy
71,457
+8,011
+13% +$380K 0.01% 506
2025
Q4
$3.23M Sell
63,446
-6,018
-9% -$308K 0.02% 371
2025
Q3
$4.12M Buy
69,464
+4,245
+7% +$248K 0.03% 313
2025
Q2
$4.56M Buy
65,219
+7,584
+13% +$516K 0.03% 291
2025
Q1
$3.92M Sell
57,635
-54,195
-48% -$4.48M 0.03% 295
2024
Q4
$9.62M Sell
111,830
-90,868
-45% -$9.83M 0.08% 192
2024
Q3
$23.9M Buy
202,698
+14,447
+8% +$1.93M 0.19% 102
2024
Q2
$27.4M Buy
188,251
+57,850
+44% +$7.67M 0.25% 83
2024
Q1
$19.9M Buy
130,401
+34,738
+36% +$4.14M 0.15% 121
2023
Q4
$12.5M Buy
95,663
+25,109
+36% +$2.48M 0.12% 138
2023
Q3
$7.77M Buy
70,554
+21,140
+43% +$1.86M 0.08% 166
2023
Q2
$4.07M Sell
49,414
-16,756
-25% -$1.37M 0.04% 237
2023
Q1
$5.48M Sell
66,170
-1,214
-2% -$86.1K 0.06% 195
2022
Q4
$4.8M Sell
67,384
-1,292
-2% -$75.7K 0.05% 200
2022
Q3
$3.65M Sell
68,676
-3,488
-5% -$187K 0.04% 224
2022
Q2
$4.12M Buy
72,164
+2,162
+3% +$120K 0.05% 220
2022
Q1
$4.04M Sell
70,002
-24,980
-26% -$1.28M 0.04% 241
2021
Q4
$5.11M Buy
+94,982
New +$5.15M 0.05% 216

Other funds holding NVO

TD Waterhouse Canada's NVO Position: Q2 2026 in Review

TD Waterhouse Canada increased its Novo Nordisk (NVO) stake by 4.8% in Q2 2026, buying an estimated $146K and bringing the position to 74,856 shares worth $3.65M. The position accounts for 0.01% of the portfolio, ranked #475.

TD Waterhouse Canada first reported a position in NVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $27.4M in Q2 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • TD Waterhouse Canada held 74,856 shares of Novo Nordisk worth $3.65M as of Q2 2026.
  • TD Waterhouse Canada bought 3,399 Novo Nordisk shares in Q2 2026, an estimated $146K.
  • Novo Nordisk made up 0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #475 holding.
  • TD Waterhouse Canada first reported a position in Novo Nordisk in Q4 2021 and has held it in 19 quarters since.
  • TD Waterhouse Canada's Novo Nordisk position peaked at $27.4M in Q2 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.